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Abstract 
In contrast to two-dimensional bioluminescence imaging, three dimensional diffuse light imaging 
tomography with integrated micro-computed tomography (DLIT-μCT) has the potential to realise 
spatial variations in infection patterns when imaging experimental animals dosed with derivatives of 
virulent bacteria carrying bioluminescent reporter genes such as the lux operon from the bacterium 
Photorhabdus luminescens. The method provides an opportunity to precisely localise the bacterial 
infection sites within the animal and enables the generation of four-dimensional movies of the 
infection cycle. Here, we describe the use of the PerkinElmer IVIS SpectrumCT in vivo imaging 
system to investigate progression of lethal systemic infection in neonatal rats following colonisation of 
the gastrointestinal tract with the neonatal pathogen Escherichia coli K1. We confirm previous 
observations that these bacteria stably colonise the colon and small intestine following feeding of the 
infectious dose from a micropipette; invading bacteria migrate across the gut epithelium into the blood 
circulation and establish foci of infection in major organs, including the brain. DLIT-μCT revealed 
novel multiple sites of colonisation within the alimentary canal, including the tongue, oesophagus and 
stomach, with penetration of the non-keratinised oesophageal epithelial surface, providing strong 
evidence of a further major site for bacterial dissemination. We highlight technical issues associated 
with imaging of infections in new born rat pups and show that the whole-body and organ bioburden 
correlates with disease severity. 
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1. Introduction 
Escherichia coli and Streptococcus agalactiae (the Group B streptococcus) are the leading 
causes of systemic life-threatening bacterial infections in the new born infant, especially among 
premature, low-birth-weight neonates [1, 2]. These opportunistic pathogens colonize mucosal 
surfaces after acquisition at or soon after birth and in a minority of cases breach the mucosal barrier 
to engender a rapidly progressive infection which the vulnerable infant is ill-equipped to counter. The 
large majority of E. coli strains causing neonatal systemic infections express the K1 capsule, a 
homopolymer of α-2,8-linked N-acetylneuraminic acid that constitutes the outermost layer of the cell 
and protects the bacteria from the host’s immune clearance mechanisms [3]. E. coli K1 is an adept 
colonizer of the neonatal gastrointestinal (GI) tract from where it may translocate into the systemic 
circulation (sometimes causing an unwanted immune response, termed sepsis), enter the central 
nervous system and gain access to the meninges, producing meningitis [4, 5]. E. coli K1 systemic 
infections display a strong age-dependency: the bacteria are benign, common constituents of the 
adult GI microbiota [6] but are potentially lethal during the first weeks of life [1, 7]. 
Neonatal bacterial infections are medical emergencies and it is consequently difficult to obtain 
insights into the underlying pathogenic mechanisms of the invading bacteria from human studies 
alone. Importantly, key features of E. coli K1 systemic infections, including the age dependency, can 
be replicated in the neonatal rat by oral administration of bacteria, a procedure that frequently initiates 
stable colonization of the GI tract [8, 9]. Rat pups colonized in the first few days postpartum develop 
lethal systemic infection as the colonizing E. coli K1 translocate from the lumen of the GI tract to the 
blood circulation to cause a persistent bacteraemia [9, 10]; they then elicit infection in multiple organs, 
including the brain [11, 12]. Bacteria appear to enter the cerebrospinal compartment predominantly at 
the choroid plexus and penetrate superficial brain tissue [11], where they give rise to localized 
inflammation through cytokine-induced pathways [13]. A week after birth, the rats become refractory 
to systemic infection, even though E. coli K1 GI colonization may persist beyond this time point [9] 
due to maturation of the protective mucus layer lining the GI tract [14]. 
Most studies with the rodent model have relied upon culling of infected animals at various 
stages after initiation of colonization with E. coli K1 and the data provide only a “snapshot” of disease 
progression with time. The presence of the pathogen in selected tissues is generally revealed by 
viable counting, or by histological or histochemical staining of tissue sections.  Real-time non-invasive 
imaging in the whole organism has the capacity to reveal complex patterns of dissemination from 
colonization sites and the dynamic process of infection over time in individual animals. The optical 
imaging of bioluminescent signals from recombinant pathogenic bacteria expressing luciferase such 
as that provided by the luxCDABE operon from the terrestrial bacterium Photorhabdus luminescens, 
in combination with ex vivo organ analysis, has been widely adopted to furnish fresh insights into 
processes of infectious disease [15-18]. With conventional 2D bioluminescence imaging, the location 
of the signal is inferred from its location at the animal surface; a quantitative 3D reconstruction of the 
source of the signal may be determined by diffuse light imaging tomography (DLIT) [19]. 
Unambiguous non-invasive localization of bioluminescent signals from small animals without the need 
for organ recovery and ex vivo quantification can at present only be achieved using multi-modality 
imaging. Here, we review our recent use of a combination of DLIT co-registered with integrated micro-
computed tomography (µCT) imaging to probe the infection dynamics of infection-susceptible 
neonatal rat pups colonized with a bioluminescent derivative of E. coli K1 strain A192PP. We discuss 
the technical challenges posed by these procedures and highlight the advantages and limitations of 
the technique. 
2. DLIT-μCT imaging: theory and practice 
 Diffuse light imaging tomography utilizes a charge-coupled device (CCD) camera and band-
pass emission filters to obtain a series of multi-spectral 2D images of bioluminescent sources within a 
living subject. The DLIT algorithms also require a measurement of the subject surface topography.  
Here the μCT scan serves a dual purpose: the air-tissue boundary aids in surface topography 
generation and provides integrated anatomical co-registration with the optical source(s). 
2.1. DLIT theory 
Diffuse tomographic analysis can be a rigorous approach to provide source depth and 
intensity information, sometimes involving complicated multi-view instrumentation [20-22] or a priori 
knowledge of allowable source distribution [23, 24]. To reduce both imaging and computational time, 
PerkinElmer’s IVIS instrumentation uses multispectral 2D image acquisitions and diffuse 
luminescence tomographic algorithms [25, 26].  Tissue absorption of light across the 500-750 nm 
spectrum, mainly by haemoglobin, is significantly decreased at the red end of the spectrum compared 
to the blue/green end of the spectrum [27]. Therefore, the light output of an in vivo bioluminescent 
source depends on the depth of tissue it must pass through, as well as its wavelength. The DLIT 
algorithms exploit this property; in 2D, shallow sources appear brighter than deep sources at the 
blue/green end of the spectrum, while deep sources appear brighter than shallow sources at the 
yellow/red end of the spectrum. The DLIT algorithms produce a 3D reconstruction of the 
bioluminescent source(s) using a non-negative least squares optimization. 
DLIT also requires a measurement of the surface topography of the imaging subject in order 
to convert exhibited light emission into a photon density map.  In the instance of DLIT- μCT, the 
surface topography is derived from the μCT scan itself by delineation of the air-tissue boundary. The 
surface topography, when combined with the series of filtered 2D bioluminescence images, results in 
an improved resolution of source parameters by providing uniqueness to the algorithms.  
2.2. DLIT- μCT in practice 
PerkinElmer’s IVIS SpectrumCT includes all hardware and software required for DLIT- μCT.  
The system consists of a cooled (-90’C), integrating CCD camera that is placed above a light-sealed 
imaging chamber (Fig. 1). The heated imaging stage is mobile along the optical axis to adjust field of 
view and the emission filter wheel contains 18 filters with 20 nm bandwidths. In order to keep a 
manageable system footprint, the x-ray source and complementary metal oxide semiconductor 
detector are fixed perpendicular to the optical axis, while the μCT projections are captured by rotating 
the subject on a unique turntable arrangement (Fig. 1). DLIT- µCT acquisition consists of a µCT scan 
followed by a sequence of multispectral 2D bioluminescence images. Image acquisition is performed 
using PerkinElmer’s Living Image® software. A standard single animal µCT scan was employed to 
provide a quality volume for co-registration while also keeping the x-ray dose low (53 mGy). 
Bioluminescence images are acquired with various emission filters in place and typically 4-6 
emission filters are chosen that cover the known spectrum of the bioluminescent probe of interest. In 
the study described here, 540, 560, 580, 600 and 620 nm filters were chosen for lux bacterial 
luciferase. The auto-exposure feature was used; this allows the software to determine the acquisition 
parameters needed to reach a target count of 10,000 for each 2D BLI image. Auto-exposure range 
parameters were adjusted to ensure maximum sensitivity: the maximum exposure time was increased 
to 5 min and the maximum bin was increased to 16. Whilst the most recent version of Living Image 
software is capable of performing ‘one-click’ reconstructions, the order of operations remains the 
same for the traditional method of reconstruction. Firstly, the subject’s surface topography is 
computed following the determination of the air-tissue boundary threshold of the µCT scan.  Secondly, 
the bioluminescent images are examined for quality and threshold levels. Images that are deemed to 
be of insufficient quality, for example too low a bioluminescent signal, are automatically excluded from 
the reconstruction algorithm, but the end-user may adjust if appropriate. After the reconstruction is 
complete, the software automatically co-registers the reconstructed bioluminescent source(s) with the 
µCT scan. Thresholds can be applied to the µCT volume in order to highlight specific anatomical 
features of the subject. 
One of the more common troubleshooting areas of lux DLIT- µCT is bioluminescence signal 
strength. The lux emission spectrum, with a peak at around 480 nm and only a small percentage 
beyond 600 nm, falls in an area of the visible spectrum that is more heavily absorbed by 
haemoglobin, so depending on the animal model, the starting signal strength may be low. This issue 
is exacerbated when the DLIT images are acquired, as each image is collecting a narrow range (20 
nm) of emitted light. Thus it is imperative that all signal impeders be removed, including animal fur, 
and pigmented animals are best avoided. Further, it is best practice to place the subjects on the 
imaging stage such that the brightest side is facing the CCD camera (i.e. facing up).  Finally, as 
mentioned above, adjusting auto-exposure parameters such that the most sensitive settings are 
allowed will help ensure sufficient signal levels.   
3. Rodent model of neonatal E. coli K1 infection 
All animal experiments described here conformed to national (U.K. Animals [Scientific 
Procedures] Act, 1986) and European (EU Directive 2010/63/EU for animal experiments) legislation 
and were approved by the Ethical Committee of the University College London and the UK Home 
Office (HO). All animal work was conducted under HO project licences PPL 80/2243 and PPL 
70/7773. 
The E. coli K1 capsule is associated with a limited number of O-serotypes, including O1, O2, 
O7, O18, O25 and O75, that are commonly found as causative agents of neonatal systemic infection 
[6, 28]. Many of these isolates readily colonize the GI tract when administered orally to neonatal rat 
pups, with colonization rates of 88-100%, but they vary in their capacity to cause bacteraemia (2-50%) 
and to induce lethality (0-25%) [9]. Clones belonging to serotype O18 tend to cause the most severe 
systemic neonatal infections in rodents [9]. In order to undertake extensive characterization of the 
basis of systemic infection due to E. coli K1, we selected the O18:K1 septicaemia isolate A192 [28], 
reported as colonizing new born Wistar rats with an incidence of 100%, inducing bacteraemia in 35% 
with survival of 75% [12]. This strain, like many other E. coli K1 strains, belongs to sequence type 95 
[29]. We enhanced the virulence of E. coli A192 by two rounds of passage through susceptible 
neonatal rats to obtain a derivative, E. coli A192PP, that produced lethal disseminated infection in all 
colonized two-day-old (P2) animals [10, 11]. The substantial enhancement of virulence was due to 
only four single nucleotide polymorphisms, each within genes involved in metabolic functions [29]. 
Feeding of 2-6 x 106 CFU mid-logarithmic E. coli K1 to P2 Wistar rat pups through an 
Eppendorf pipette established a rapidly progressive lethal infection; as the pups matured over a seven 
day period, they became progressively less susceptible to bacteraemia and to the lethal effect (Fig. 
2), but not to GI colonization [30, 31]. For DLIT-μCT imaging, we engineered E. coli A192PP for 
expression of the bioluminescence phenotype by introduction of the lux operon through mini-Tn5 
mutagenesis [12]. It is imperative to ensure that bioluminescent conjugants produce a strong 
bioluminescent signal over the course of the growth cycle in the absence of the selective antibiotic to 
confirm constitutive and stable expression of the lux operon [32], display a rate of growth in nutrient-
replete medium comparable to that of the parent strain and retain a comparable level of virulence in 
the animal model. We investigated over thirty bioluminescent derivatives of E. coli A192PP and 
identified only one suitable lux strain for detailed in vivo investigations, E. coli A192PP-lux2 (Fig. 3), 
which showed only a small reduction in virulence compared to the parent [12]. Thus, three-
dimensional DLIT-μCT, in combination with enumeration by culture of organ bioburden and two-
dimensional bioluminescent imaging, was employed to illustrate temporal and spatial aspects of 
systemic infection in P2 rat pups following oral administration of E. coli A192PP-lux2 [12]. Bacteria 
translocated from the lumen of the GI tract to the blood compartment and entered the central nervous 
system with colonisation of the brain restricted to the meningeal surfaces. DLIT-μCT demonstrated for 
the first time the colonisation of additional sites from the oral bolus; these included keratinised and 
non-keratinised surfaces of the oesophagus and the tongue. The total E. coli K1 burden increased 
with time and was highly correlated with severity of symptoms.  
3.1. Preparation and use of neonatal rat pups for DLIT-μCT imaging of infection  
Neonatal rats require immobilisation for up to forty minutes in order to achieve high quality DLIT-μCT 
images. We have noted, as have others [33, 34], that very young neonatal rat pups do not respond 
favourably to anaesthetic drugs such as isoflurane and it has been recorded that prolonged exposure 
of the developing rat brain to commonly used general anaesthetics triggers widespread regional 
apoptotic neurodegeneration [34-36] and increases blood-brain barrier permeability [37], which is 
likely to influence the outcome of neurotropic E. coli K1 infections. Nevertheless, it was not possible to 
immobilise P2 pups for sufficient time without sedation and it proved equally difficult to constrain the 
infection-resistant P9 pups that we have used extensively in our studies of age-related susceptibility 
to infection. We subsequently determined that sufficient sedation of P2 pups could be induced with 
5% isoflurane followed by maintenance under 2.5% isoflurane [12]. Pups were culled after 3D DLIT-
μCT imaging; we deemed such destructive sampling necessary as repeated or prolonged induction of 
anaesthesia with isoflurane increases the risk of maternal rejection [38], neonatal rats are more prone 
to post-anaesthesia complications than adults [39] and anaesthesia increases the risk of progression 
of a number of non-infectious conditions [40, 41]. We cannot exclude the possibility that similar 
modifications may be relevant to bacterial infectious disease. 
Thus, progression of infection was monitored with DLIT-μCT by selection of pups colonised 
with E. coli K1 at various times after oral dosing of the pathogen at P2 and by adopting a multi-
imaging approach [12]. DLIT-μCT was combined with 2D bioluminescent imaging (2DBLI) by both 
destructive and longitudinal sampling and enumeration of organ bioburden by traditional viable 
counting techniques, to obtain a comprehensive picture of dissemination, replication and invasion of 
the pathogen (Fig. 4). As expected, whole-body and organ bioburden correlated with disease severity. 
2D images could be obtained relatively quickly without sedation and pups were sufficiently 
immobilised using black cloth supports placed either side and sometimes behind the pup once the 
animal had settled in the heated imaging chamber. For longitudinal studies, pups were rubbed against 
their littermates and bedding to prevent maternal rejection and then labelled with a non-scented 
marker pen suitable for skin application. DLIT-μCT videos of infected P2 pups can be viewed by 
following the links in the supplemental files for reference [12]: 
http://iai.asm.org/content/83/12/4528/suppl/DCSupplemental.  
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Figure legends 
Figure 1. Schematic of the IVIS SpectrumCT – an advanced 3D combined optical and low dose µCT 
imaging system, allowing the simultaneous collection of molecular and anatomical data both non-
invasively and longitudinally from experimental mice and rats. The automated gantry moves vertically 
to allow different fields of view for the collection of optical images (grayscale photos) and data (e.g., 
bioluminescence), while the flat panel detector and X-ray source of the µCT rotate horizontally to 
acquire full 3D X-ray data sets.  
Figure 2. Age dependency of systemic infection following oral administration of E. coli A192PP to 
neonatal rat pups (n=24 for each group) aged from two days (P2) to nine days (P9). Adapted from 
Dalgakiran et al [23]. 
Figure 3. Stable constitutive bioluminescence of E. coli A192PP-lux2 and E. coli A192PP-lux12. The 
former conjugant was selected for imaging of E. coli K1 systemic infection due to retention of 
virulence in the neonatal rat and superior bioluminescence properties. (A) 2DBLI of A192PP-lux2 
(tubes 1 & 2), A192PP-lux12 (tubes 3 & 4) and Citrobacter rodentium strain ICC180 (employed as 
described in ref 24) for comparison. (B) Mueller-Hinton agar cultures of (top) of A192PP-lux2 and 
A192PP-lux12; (bottom) A192PP wild type and C. rodentium ICC180; visualized by 2DBLI. Images of 
colonies of A192PP-lux2 (C) and A192PP-lux12 (D) obtained using the Bio-Rad ChemiDoc 
bioluminescence imaging system.  
Figure 4. Dissemination of E. coli A192PP-lux2 to regional lymph nodes in live animals and excised 
nodes 72 h after oral application of 2-6 X 106 CFU bacteria, revealed by 2DBLI and DLIT-μCT. Arrows 
indicate excised tissues. Images were collected from live animals; they were then sacrificed, organs 
collected and images obtained immediately. Representative images of whole animals and excised 
organs are shown; different animals were used to generate each image. Copyright ©American Society 
for Microbiology, [Infection and Immunity 2015; 83, 4528-4540. doi: 10.1128/IAI.00953-15].  
 
 
 
 
Appendix 1 
The equipment needed to conduct DLIT-μCT investigations with small animals is available 
commercially. Details of equipment and supply lists, and general data relevant to the technique is 
available from PerkinElmer: http://www.perkinelmer.com/product/ivis-instrument-spectrum-ct-120v-
128201  
 
